Collegium Pharmaceutical, Inc.

COLL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$169,946$117,348$96,192$70,565
Short-Term Investments$135,767$104,805$101,582$92,198
Receivables$233,949$213,023$228,710$228,540
Inventory$38,052$38,148$37,218$35,560
Other Curr. Assets$36,156$75,887$63,851$55,394
Total Curr. Assets$613,870$549,211$527,553$482,257
Property Plant & Equip (Net)$16,681$18,166$19,395$20,151
Goodwill$145,925$147,936$150,760$162,333
Intangibles$724,983$780,456$835,930$891,402
Long-Term Investments$1,054$0$0$0
Tax Assets$102,477$91,967$91,665$98,033
Other NC Assets$2,338$4,895$6,085$9,415
Total NC Assets$993,458$1,043,420$1,103,835$1,181,334
Other Assets$0$0$0$0
Total Assets$1,607,328$1,592,631$1,631,388$1,663,591
Liabilities
Payables$7,647$10,890$17,853$3,934
Short-Term Debt$65,955$65,921$65,887$65,854
Tax Payable$0$9,272$17,388$15,185
Deferred Revenue$667$0$10,000$10,000
Other Curr. Liab.$378,660$378,526$375,582$414,537
Total Curr. Liab.$452,929$464,609$486,710$509,510
LT Debt$870,313$763,189$778,326$793,444
Deferred Rev, NC$9,278$10,000$10,000$10,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$122,627$121,918$121,795
Total NC Liab.$879,591$895,816$910,244$925,239
Other Liabilities$0$0$0$0
Cap. Leases$4,501$6,191$6,503$6,810
Total Liabilities$1,332,520$1,360,425$1,396,954$1,434,749
Equity
Pref Stock$0$0$0$0
Common Stock$41$40$40$40
Retained Earnings-$118,092-$149,599-$161,582-$163,999
AOCI$292$337$241$55
Other Equity$392,567$381,428$395,735$392,746
Total Equity$274,808$232,206$234,434$228,842
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,607,328$1,592,631$1,631,388$1,663,591
Net Debt$766,322$711,762$748,021$788,733